"Trump, for whatever reason, is perceived amongst conservative men as the pinnacle of masculinity," one political science ...

The UCLA trial is currently enrolling patients.

Butterfly Medical announced that it completed the final 12-month follow-up for all patients in a study of its prostatic retraction device.

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

The prospective, double-blind, randomized controlled trial (RCT) enrolled 244 patients to evaluate the Butterfly Prostatic Retraction Device, a minimally invasive, reversible implant that mechanically ...

Kevin Blair, the new CEO of Pinnacle Financial Partners, "conquers the wall" at a team building exercise in Nashville, Tennessee. In the banking world, mergers of equals have a reputation for ...

Pinnacle Financial Partners announced Friday morning the completion of its merger with Synovus Financial Corp. — a transaction valued at about $8.6 billion. According to a release, though the newly ...

Pinnacle CEO Kevin Blair (right) has succeeded the bank's co-founder, Terry Turner (left), who is now chairman of the bank's holding company. Key insight: Pinnacle took a little over five months to ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether combining precision radiation with a targeted radioactive therapy drug can ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

BOSTON and YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- Butterfly Medical, developer of a proprietary non-surgical solution for benign prostatic hyperplasia (BPH), today announced the successful ...